Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis [Phase 4]

View source ↗

Summary

This Phase 4 trial comparing Fluomizin (dequalinium chloride) to oral metronidazole for bacterial vaginosis was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluomizin (dequalinium chloride)
  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Medinova AG | Conditions: Bacterial Vaginosis, Vaginal Infection | Phase 4 | Status: TERMINATED | Results posted: 2024-10-16